Simparica Trio 6mg for Dogs - Pack of 6 Chewable Tablets

Description

Simparica Trio 6mg is a chewable parasite treatment for dogs weighing over 2.5kg to 5kg, supplied in a pack of six tablets. Each tablet contains 6mg sarolaner, 0.12mg moxidectin and 25mg pyrantel, combining activity against fleas, ticks and specified internal worms. This presentation is intended for dogs that need treatment against external parasites and gastrointestinal nematodes at the same time. Simparica Trio 6mg also provides concurrent protection against certain other parasites, including heartworm and lungworm, within the appropriate programme. The palatable oral formulation can be given with or without food, providing an alternative to products applied to the skin. For a dog remaining within this weight band and continuing monthly treatment, the six-tablet pack provides six monthly doses of the same strength.

Fleas can cause persistent scratching, nibbling at the coat and irritated skin, and some dogs develop flea allergy dermatitis after exposure to flea saliva. Ticks attach to the skin and take a blood meal, sometimes remaining hidden beneath the coat. Sarolaner in Simparica Trio 6mg disrupts nerve signalling in these parasites, leading to their death. Flea-killing activity persists for five weeks, while tick-killing activity lasts five weeks against Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus, and four weeks against Dermacentor reticulatus. Simparica Trio 6mg kills parasites after they begin feeding; it does not repel them before they bite. Flea control also benefits from washing pet bedding and vacuuming areas where eggs and immature stages collect. Treating the dog and reducing the environmental flea population address different parts of an infestation.

The worming ingredients in Simparica Trio 6mg broaden its activity beyond fleas and ticks. Pyrantel interferes with the neuromuscular function of susceptible intestinal worms, while moxidectin acts on parasite nerve and muscle channels. The authorised gastrointestinal coverage includes specified stages of roundworms and hookworms, including Toxocara canis and Ancylostoma caninum. These worms may contribute to digestive upset, poor condition or impaired growth, particularly in young dogs, although an infected dog may not always show obvious signs. Simparica Trio 6mg is absorbed and distributed after oral administration, allowing its ingredients to work in the relevant parts of the body. Its worm spectrum is specific: the product does not provide universal coverage against every intestinal parasite, and established tapeworm infections require a medicine with the appropriate indication.

Simparica Trio 6mg also has authorised uses involving Angiostrongylus vasorum, the lungworm associated with infection from slugs and snails, and prevention of Dirofilaria immitis heartworm disease. Monthly administration can prevent angiostrongylosis by reducing infection with immature adult lungworms, and the product is also authorised for treatment of this parasite under the relevant schedule. Heartworm prevention acts against developing stages rather than removing established adult heartworms. Simparica Trio 6mg additionally prevents establishment of Thelazia callipaeda eyeworm infection and is authorised for sarcoptic mange and demodicosis. These conditions require their own treatment schedules. Flea killing also reduces the risk of flea-transmitted Dipylidium caninum infection for one month, an indirect benefit that should not be confused with a direct tapeworm treatment.

Give Simparica Trio 6mg as a whole tablet. Many dogs accept the chew when it is offered directly; it can also be given with food or placed into the mouth. The tablets should not be divided. This strength covers dogs above 2.5kg and up to 5kg inclusive, so a dog weighing exactly 2.5kg belongs to the lower weight band. Growing puppies can move into a different presentation before a six-tablet pack has been used. Simparica Trio 6mg is generally considered from eight weeks of age; use in younger puppies requires an individual veterinary benefit–risk assessment. Where repeat administration is needed, the minimum interval is one month. The duration of flea or tick activity should not be used to extend an agreed monthly programme for protection against other parasites.

The three ingredients in Simparica Trio 6mg make it useful when a dog has a combined parasite need, with selection based on exposure and the parasites being treated or prevented. For dogs visiting heartworm areas, testing forms part of the prevention programme because existing adult infection needs a different approach. Simparica Trio 6mg is not recommended for pregnant, lactating or breeding dogs because safety in these groups has not been established. Very rare adverse effects include digestive upset, lethargy, reduced appetite and neurological signs such as tremor, unsteadiness or seizures; seek veterinary advice if these occur. Keep each chew in its blister until needed and store the pack out of reach of children and animals, as a palatable medicine may be eaten in excess if left accessible.

What weight of dog is Simparica Trio 6mg for?

Simparica Trio 6mg is the presentation for dogs weighing over 2.5kg and up to 5kg inclusive. A dog weighing exactly 2.5kg belongs to the lower strength band. The pack contains six whole chewable tablets, and growing dogs may need a different strength as their weight changes.

What does Simparica Trio 6mg treat?

It treats fleas, ticks and specified gastrointestinal roundworms and hookworms when combined treatment is needed. It also has authorised uses for lungworm, heartworm prevention, eyeworm prevention, sarcoptic mange and demodicosis. The appropriate schedule depends on the parasites involved and the dog’s exposure or diagnosed infection.

Does Simparica Trio protect against lungworm?

Simparica Trio is authorised for prevention of angiostrongylosis by reducing infection with immature adult Angiostrongylus vasorum. It also has an indication for treatment of this lungworm. Prevention involves monthly administration within an appropriate combined parasite programme; treatment of an existing infection needs its specific veterinary schedule.

How long does a six-tablet pack last?

A pack of six provides six monthly doses when one tablet is needed each month and the dog remains in the over 2.5–5kg weight band. Some parasite conditions have different treatment courses, so the pack’s duration follows the programme selected for the individual dog.

Should Simparica Trio be given with food?

Simparica Trio can be given with or without food. Many dogs accept the palatable tablet directly, but it may also be offered with food or placed into the mouth. Give the tablet whole and make sure it has been swallowed before considering the administration complete.

Does Simparica Trio treat tapeworms?

Simparica Trio does not directly treat an established tapeworm infection. By killing fleas, it reduces the risk of flea-transmitted Dipylidium caninum infection for one month. That indirect effect differs from tapeworm treatment, which requires a medicine authorised for the tapeworm species involved.